Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
24 hours after taking certain diabetes medications (like insulin or sulfonylureas, if youre using them together with GLP-1s) Between meals, when blood sugar naturally dips During or after exercise, especially if you havent eaten enough beforehand After dose changes, as your body adapts to stronger appetite-suppressing effects During rapid weight loss or dietary changes, when your energy intake is lower than usual Whos at higher risk
These actions lead to a prolonged or durable action after ceasing GLP-1 treatment (131)
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L
Fact: There is no biological evidence that these two interfere with one another
